InvestorsHub Logo
Followers 664
Posts 46911
Boards Moderated 2
Alias Born 03/30/2009

Re: someconcerns post# 29519

Sunday, 04/19/2015 7:48:23 PM

Sunday, April 19, 2015 7:48:23 PM

Post# of 48316
$ONCS Merck has supplied its drug, Keytruda, to one of the trials that OncoSec is participating in. No doubt, Merck will be watching closely, as it will be watching the other trials in which Keytruda is being tested.

BTW, I came across this article in the WSJ re: Keytruda and melanoma:

Merck’s Keytruda Shows Improved Survival Odds in Melanoma

Immunotherapy displayed better survival rates compared with Bristol-Myers’s Yervoy


http://www.wsj.com/articles/mercks-keytruda-shows-improved-survival-odds-for-melanoma-patients-1429448169

The article is dated today but, wasn't there a trial, involving Keytruda, that was stopped early because Merck's drug showed promising results over a rival's drug? Isn't this article discussing the same?

"You should grow like an onion with your head in the ground."--Yiddish epithet